行情

ATRC

ATRC

AtriCure
NASDAQ

实时行情|Nasdaq Last Sale

62.41
+0.17
+0.27%
已收盘, 16:00 02/24 EST
开盘
60.33
昨收
62.24
最高
63.00
最低
58.41
成交量
91.81万
成交额
--
52周最高
67.01
52周最低
23.17
市值
28.10亿
市盈率(TTM)
-53.9926
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
Leerink Partners相信Atricure(ATRC)不会就此停止
In a report released today, Danielle Antalffy from Leerink Partners maintained a Buy rating on Atricure (ATRC), with a price target of $78.00. The
SmarterAnalyst · 1天前
每日生物技术动向:博士伦与伊坎(Icahn)休战,辉瑞公司的脑炎疫苗获得优先审查,BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23)
Benzinga · 1天前
Canaccord Genuity相信Atricure(ATRC)不会就此止步
Canaccord Genuity analyst William Plovanic maintained a Buy rating on Atricure (ATRC) today and set a price target of $69.00. The company's shares closed
SmarterAnalyst · 1天前
Oppenheimer相信Atricure(ATRC)仍有增长空间
Oppenheimer analyst Suraj Kalia assigned a Buy rating to Atricure (ATRC) today and set a price target of $65.00. The company's shares closed last Tuesday
SmarterAnalyst · 1天前
AtriCure:第四季度收益洞察
Shares of AtriCure (NASDAQ:ATRC) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 51.35% year over year to ($0.18), which beat the estimate of ($0.28). Revenue of $57,725,000 declined by 5.86%...
Benzinga · 1天前
8-K:AtriCure,Inc.
(EDGAR Online via COMTEX) -- atrc-20210223x8k false000132388500013238852021-02-232021-02-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 1天前
AtriCure Q4调整EPS $(0.18)超出$(0.28)估计,销售额$ 57.70M小姐$ 58.10M估计
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.28) by 35.71 percent. This is a 51.35 percent increase over losses of $(0.37) per share from the same
Benzinga · 1天前
AtriCure,Inc.举办收益电话会议
February 23, 2021 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / February 23, 2021 / AtriCure, Inc. (NASDAQ:ATRC) will be discussing their earnings...
ACCESSWIRE · 1天前
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解ATRC最新的财务预测,通过ATRC每股收益,每股净资产,每股现金流等数据分析AtriCure近期的经营情况,然后做出明智的投资选择。
分析师评级

8位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测ATRC价格均价为70.14,最高价位78.00,最低价为65.00。
EPS
机构持股
总机构数: 295
机构持股: 4,800.64万
持股比例: 106.63%
总股本: 4,502.32万
类型机构数股数
增持
67
525.34万
建仓
60
205.35万
减持
57
543.97万
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.93%
医疗设备和用品
+0.66%
高管信息
Chairman/Independent Director
Scott Drake
President/Chief Executive Officer/Director
Michael Carrel
Chief Financial Officer/Senior Vice President
M. Andrew Wade
Chief Financial Officer
Angela Wirick
Chief Operating Officer
Douglas Seith
Senior Vice President/Director of Marketing
Justin Noznesky
Chief Technology Officer
Salvatore Privitera
Independent Director
Mark Collar
Independent Director
Daniel Florin
Independent Director
Regina Groves
Independent Director
B. Kristine Johnson
Independent Director
Mark Lanning
Independent Director
Karen Prange
Independent Director
Sven Wehrwein
Independent Director
Robert White
  • 分红
  • 拆股
  • 内部人交易
暂无数据
ATRC 简况
AtriCure, Inc.是一家提供心房颤动(Afib)解决方案的医疗设备公司。该公司开发、制造和销售主要用于心脏组织的手术消融设备及用于左心耳预防的系统。该公司拥有各种用于心脏组织消融的产品系列,包括其用于治疗经历某些开放伴随手术患者的持续和长期持续形式的Afib的Isolator Synergy Ablation System。其Isolator Synergy System包括其Isolator Synergy夹钳、射频(RF)发生器和相关开关盒,以及为持续和长期持续性Afib伴随提供疗法。它有两个主要用于心脏组织消融的产品,包括Radio Frequency Ablation Devices和cryoICE Cryoablation System,以及1个用于左心耳预防的产品。

微牛提供AtriCure Inc.(NASDAQ-ATRC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ATRC股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ATRC股票基本功能。